Summary of Veterans Administration Phase II cooperative study for LAAM and methadone.
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D013287:Illicit Drugs / Q000008:administration & dosage; D008297:Male; D008691:Methadone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D008692:Methadyl Acetate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009020:Morphine / Q000652:urine; D010352:Patient Dropouts; D012646:Self Administration; D014481:United States; D014493:United States Department of Veterans Affairs
D013287:Illicit Drugs; D009020:Morphine; D008692:Methadyl Acetate; D008691:Methadone